| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |